Course NURS-6630C-7/NURS-6630N-7-Approaches to Treatment
Winter Qtr 11/25-02/16-PT27
Test Week 6 Midterm Exam
Attempt 72 out of 75 points
Score
Time Elapsed 1 hour, 42 minutes out of 2 hours
Results Submitted Answers
Displayed
• Question 1
1 out of 1 points
During assessment a patient states “Why are you asking me about my heart, I am here for my head”,
the PMHNP’s best response is:
Selected D.
Answer: “Anxiety can cause cortisol levels to increase and when this happens frequently it
puts you at risk for comorbidities such as type 2 diabetes.”
• Question 2
1 out of 1 points
During gene expression, what must occur prior to a gene being expressed?
Selected A.
Answers: Transcription factor must bind to the regulatory region within thecell’s nucleus.
• Question 3
1 out of 1 points
The PMNHP is assessing a 29-year-old client who takes antipsychotics that block D2receptors.
This client has begun to develop a common side effect of this medication. What is this side
effect?
Selected D.
Answer: Tardive dyskinesia
• Question 4
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor forwhich
possible effect?
Selected D.
Answer: All of the
above
• Question 5
1 out of 1 points
, A patient is prescribed 50 mg of desvenlafaxine to take every other day for majordepressive disorder.
What does the PMHNP understand about this patient?
Selected C.
Answer: The patient has severe renal
impairment.
• Question 6
1 out of 1 points
A patient is prescribed sertraline to treat panic disorder. Knowing that sertraline can initially
cause anxiety or insomnia, what should the PMHNP do?
Selected B.
Answer: Prescribe short-acting benzodiazepine for 2 weeks, thendiscontinue.
• Question 7
1 out of 1 points
Though medications have the ability to target neurotransmitter release into the synapse by the presynaptic
neuron it is not always necessary. The PMHNP understands that this is because:
Selected C.
Answer: Neurotransmitters can spread bydiffusion.
• Question 8
1 out of 1 points
A patient is diagnosed with schizophrenia. What increases the patient’s potential tomediate the
cognitive symptoms of the disease?
Selected A.
Answer: Achieving underactivity of the mesocorticol projections to the
prefrontal cortex
• Question 9
1 out of 1 points
The PMHNP spends a session with a client and notices behaviors correlating with a potential
manic episode. All of the following are possible manic symptoms the PMHNPcould observe
except:
Selected D.
Answer: A low self esteem
• Question 10
1 out of 1 points
A patient who is prescribed MAO inhibitors asks about whether he can continue taking pseudoephedrine
to relieve his congestion. Which response by the PMHNP indicates properunderstanding of drug-drug
interactions?
Selected D.
Answer: “Decongestants should be avoided due to risk of
hypertensive crisis.”
• Question 11
Winter Qtr 11/25-02/16-PT27
Test Week 6 Midterm Exam
Attempt 72 out of 75 points
Score
Time Elapsed 1 hour, 42 minutes out of 2 hours
Results Submitted Answers
Displayed
• Question 1
1 out of 1 points
During assessment a patient states “Why are you asking me about my heart, I am here for my head”,
the PMHNP’s best response is:
Selected D.
Answer: “Anxiety can cause cortisol levels to increase and when this happens frequently it
puts you at risk for comorbidities such as type 2 diabetes.”
• Question 2
1 out of 1 points
During gene expression, what must occur prior to a gene being expressed?
Selected A.
Answers: Transcription factor must bind to the regulatory region within thecell’s nucleus.
• Question 3
1 out of 1 points
The PMNHP is assessing a 29-year-old client who takes antipsychotics that block D2receptors.
This client has begun to develop a common side effect of this medication. What is this side
effect?
Selected D.
Answer: Tardive dyskinesia
• Question 4
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor forwhich
possible effect?
Selected D.
Answer: All of the
above
• Question 5
1 out of 1 points
, A patient is prescribed 50 mg of desvenlafaxine to take every other day for majordepressive disorder.
What does the PMHNP understand about this patient?
Selected C.
Answer: The patient has severe renal
impairment.
• Question 6
1 out of 1 points
A patient is prescribed sertraline to treat panic disorder. Knowing that sertraline can initially
cause anxiety or insomnia, what should the PMHNP do?
Selected B.
Answer: Prescribe short-acting benzodiazepine for 2 weeks, thendiscontinue.
• Question 7
1 out of 1 points
Though medications have the ability to target neurotransmitter release into the synapse by the presynaptic
neuron it is not always necessary. The PMHNP understands that this is because:
Selected C.
Answer: Neurotransmitters can spread bydiffusion.
• Question 8
1 out of 1 points
A patient is diagnosed with schizophrenia. What increases the patient’s potential tomediate the
cognitive symptoms of the disease?
Selected A.
Answer: Achieving underactivity of the mesocorticol projections to the
prefrontal cortex
• Question 9
1 out of 1 points
The PMHNP spends a session with a client and notices behaviors correlating with a potential
manic episode. All of the following are possible manic symptoms the PMHNPcould observe
except:
Selected D.
Answer: A low self esteem
• Question 10
1 out of 1 points
A patient who is prescribed MAO inhibitors asks about whether he can continue taking pseudoephedrine
to relieve his congestion. Which response by the PMHNP indicates properunderstanding of drug-drug
interactions?
Selected D.
Answer: “Decongestants should be avoided due to risk of
hypertensive crisis.”
• Question 11
